Header cover image

Global Pharmaceuticals & Biotech Inefficient Market Opportunities

UPDATED Jul 03, 2022

Less coverage brings about more information asymmetry and more opportunities to buy mispriced stocks. Companies valued at less than US$500M with low PE and PEG.

8 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
XOMAXOMAUS$20.840.2%-37.4%US$238.0mUS$62.50PE19.8xE58.1%n/a
PHAREgyptian International Pharmaceutical Industriesج.م29.66-1.0%-34.7%ج.م2.9bج.م67.98PE5.4xE16.2%5.1%
B8FEBiofrontera€2.1224.7%-60.0%€65.2m€6.18PE4.3xE30.9%n/a
B8FEBiofrontera€2.2237.9%-51.7%€65.2m€6.47PE4.3xE30.9%n/a
BFAG.YBiofrontera€2.272.3%-63.3%€65.2m€6.61PE4.3xE30.9%n/a
AYUR.FAyurcann HoldingsCA$0.081-15.6%n/aCA$12.1mn/aPE30.3xE138.3%n/a
AYURAyurcann HoldingsCA$0.10-9.1%-52.4%CA$12.1mn/aPE30.3xE138.3%n/a
3ZQ0Ayurcann HoldingsCA$0.067-16.8%-48.2%CA$12.1mn/aPE30.3xE138.3%n/a
Page 1 of 1